SI3100725T1 - Sredstvo, ki vsebuje derivate alkilnega etra ali sol le-tega, ki izboljšuje učinek rehabilizacije po poškodbi živčevja - Google Patents

Sredstvo, ki vsebuje derivate alkilnega etra ali sol le-tega, ki izboljšuje učinek rehabilizacije po poškodbi živčevja

Info

Publication number
SI3100725T1
SI3100725T1 SI201531278T SI201531278T SI3100725T1 SI 3100725 T1 SI3100725 T1 SI 3100725T1 SI 201531278 T SI201531278 T SI 201531278T SI 201531278 T SI201531278 T SI 201531278T SI 3100725 T1 SI3100725 T1 SI 3100725T1
Authority
SI
Slovenia
Prior art keywords
salt
alkyl ether
enhancing agent
nerve injury
ether derivative
Prior art date
Application number
SI201531278T
Other languages
English (en)
Inventor
Takuya Takahashi
Tomohiro Okuda
Original Assignee
Fujifilm Toyama Chemical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Toyama Chemical Co., Ltd. filed Critical Fujifilm Toyama Chemical Co., Ltd.
Publication of SI3100725T1 publication Critical patent/SI3100725T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5052Proteins, e.g. albumin
    • A61K9/5057Gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI201531278T 2014-01-31 2015-01-30 Sredstvo, ki vsebuje derivate alkilnega etra ali sol le-tega, ki izboljšuje učinek rehabilizacije po poškodbi živčevja SI3100725T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014017587 2014-01-31
PCT/JP2015/052617 WO2015115582A1 (ja) 2014-01-31 2015-01-30 アルキルエーテル誘導体またはその塩を含有する神経損傷後のリハビリテーション効果促進剤
EP15743367.3A EP3100725B1 (en) 2014-01-31 2015-01-30 Post nerve injury rehabilitation effect-enhancing agent comprising an alkyl ether derivative or a salt thereof

Publications (1)

Publication Number Publication Date
SI3100725T1 true SI3100725T1 (sl) 2020-08-31

Family

ID=53757150

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201531278T SI3100725T1 (sl) 2014-01-31 2015-01-30 Sredstvo, ki vsebuje derivate alkilnega etra ali sol le-tega, ki izboljšuje učinek rehabilizacije po poškodbi živčevja

Country Status (26)

Country Link
US (2) US10039744B2 (sl)
EP (1) EP3100725B1 (sl)
JP (3) JP5837726B1 (sl)
KR (1) KR102346219B1 (sl)
CN (1) CN106061478B (sl)
AU (1) AU2015211753B2 (sl)
BR (1) BR112016017747A2 (sl)
CA (1) CA2938184C (sl)
CY (1) CY1123154T1 (sl)
DK (1) DK3100725T3 (sl)
ES (1) ES2792950T3 (sl)
HK (1) HK1226298A1 (sl)
HR (1) HRP20200796T1 (sl)
HU (1) HUE050400T2 (sl)
IL (1) IL246925B (sl)
LT (1) LT3100725T (sl)
MX (1) MX2016009751A (sl)
MY (1) MY179290A (sl)
PH (1) PH12016501507A1 (sl)
PL (1) PL3100725T3 (sl)
PT (1) PT3100725T (sl)
RS (1) RS60462B1 (sl)
RU (1) RU2680247C2 (sl)
SG (2) SG11201606173TA (sl)
SI (1) SI3100725T1 (sl)
WO (1) WO2015115582A1 (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3100725B1 (en) * 2014-01-31 2020-05-06 FUJIFILM Toyama Chemical Co., Ltd. Post nerve injury rehabilitation effect-enhancing agent comprising an alkyl ether derivative or a salt thereof
US11304928B2 (en) 2015-12-25 2022-04-19 Fujifilm Toyama Chemical Co., Ltd. Tablet comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof
JP7176957B2 (ja) * 2016-12-28 2022-11-22 富士フイルム富山化学株式会社 外用組成物
JP7079209B2 (ja) 2016-12-28 2022-06-01 富士フイルム富山化学株式会社 医薬組成物およびその製造方法
CN110121342A (zh) * 2016-12-28 2019-08-13 富士胶片富山化学株式会社 医药组合物
JP7057286B2 (ja) * 2016-12-28 2022-04-19 富士フイルム富山化学株式会社 医薬組成物
EP3636261A4 (en) * 2017-06-02 2020-06-10 FUJIFILM Toyama Chemical Co., Ltd. AGENT FOR PREVENTING OR TREATING TAUOPATHY
CN116492335A (zh) 2017-06-02 2023-07-28 富士胶片富山化学株式会社 脑萎缩预防或治疗剂
IL270910B2 (en) 2017-06-02 2024-03-01 Fujifilm Toyama Chemical Co Ltd 1-(3-(2-(1-benzothiophene-5-yl)ethoxy)propyl)aztidine-3-ol or a salt thereof for use in suppressing cerebral atrophy
WO2018221728A1 (ja) 2017-06-02 2018-12-06 富山化学工業株式会社 アルツハイマー型認知症予防または治療剤
JP7256118B2 (ja) 2017-06-02 2023-04-11 富士フイルム富山化学株式会社 アミロイドβ蛋白質量減少剤
JP7227914B2 (ja) 2017-10-30 2023-02-22 富士フイルム富山化学株式会社 エモパミル結合タンパク質結合剤およびその利用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100956990B1 (ko) 2001-10-19 2010-05-11 토야마 케미칼 컴퍼니 리미티드 알킬에테르유도체 또는 그 염
AU2002355033A1 (en) * 2001-11-29 2003-06-10 Japan Science And Technology Agency Method of constructing spinal injury model monkey and utilization thereof
ES2379948T3 (es) * 2002-06-14 2012-05-07 Toyama Chemical Co., Ltd. Composición medicinal que comprende Tacrine o Donepezil para mejorar la función cerebral
MXPA05011125A (es) * 2003-04-17 2005-12-14 Toyama Chemical Co Ltd Remedio preventivo para enfermedades del nervio retiniano que contienen derivados de eter de alquilo o sales de los mismos.
ES2398934T3 (es) 2005-03-28 2013-03-22 Toyama Chemical Co., Ltd. Proceso de la producción de1-(3-(2-(1-benzotiofen-5-il)etoxi)propil)acetidin-ol o sales del mismo
RU2397169C2 (ru) * 2005-03-28 2010-08-20 Тояма Кемикал Ко., Лтд. Способ получения 1-(3-(2-(1-бензотиофен-5-ил)этокси) пропил)азетидин-3-ола или его солей
US8119625B2 (en) * 2006-04-26 2012-02-21 Toyama Chemical Co., Ltd. Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof
PL2011796T3 (pl) * 2006-04-26 2015-03-31 Toyama Chemical Co Ltd Induktor neurogenezy lub środek terapeutyczny do stosowania w neuropatii zawierający pochodną eteru alkilowego lub jej sól
EP3100725B1 (en) * 2014-01-31 2020-05-06 FUJIFILM Toyama Chemical Co., Ltd. Post nerve injury rehabilitation effect-enhancing agent comprising an alkyl ether derivative or a salt thereof

Also Published As

Publication number Publication date
JP6825074B2 (ja) 2021-02-03
CN106061478A (zh) 2016-10-26
NZ722542A (en) 2021-07-30
MX2016009751A (es) 2016-11-08
IL246925B (en) 2019-10-31
SG11201606173TA (en) 2016-08-30
BR112016017747A2 (pt) 2017-08-08
AU2015211753B2 (en) 2019-09-12
ES2792950T3 (es) 2020-11-12
US10039744B2 (en) 2018-08-07
DK3100725T3 (da) 2020-06-22
CA2938184C (en) 2021-11-23
CA2938184A1 (en) 2015-08-06
LT3100725T (lt) 2020-08-10
US10471044B2 (en) 2019-11-12
HUE050400T2 (hu) 2020-12-28
MY179290A (en) 2020-11-03
HK1226298A1 (zh) 2017-09-29
RU2016135236A (ru) 2018-03-02
PH12016501507A1 (en) 2017-02-06
JP6642914B2 (ja) 2020-02-12
JP2016074676A (ja) 2016-05-12
EP3100725A4 (en) 2017-08-30
RS60462B1 (sr) 2020-07-31
AU2015211753A1 (en) 2016-08-11
SG10201907035TA (en) 2019-09-27
IL246925A0 (en) 2016-09-29
KR102346219B1 (ko) 2022-01-04
US20170165227A1 (en) 2017-06-15
KR20160113281A (ko) 2016-09-28
PT3100725T (pt) 2020-06-17
JP2020073542A (ja) 2020-05-14
JPWO2015115582A1 (ja) 2017-03-23
CY1123154T1 (el) 2021-10-29
RU2016135236A3 (sl) 2018-08-30
EP3100725B1 (en) 2020-05-06
RU2680247C2 (ru) 2019-02-19
PL3100725T3 (pl) 2020-11-16
HRP20200796T1 (hr) 2020-08-07
US20180289668A1 (en) 2018-10-11
WO2015115582A1 (ja) 2015-08-06
JP5837726B1 (ja) 2015-12-24
EP3100725A1 (en) 2016-12-07
CN106061478B (zh) 2019-04-30

Similar Documents

Publication Publication Date Title
HK1226298A1 (zh) 含有烷基醚衍生物或其鹽的神經損傷後的康復效果促進劑
GB201809461D0 (en) Leg movement stimulator device
ZA201607866B (en) Solid-stabilized emulsion
DK3233221T3 (da) Træningsindretning
IL249356A0 (en) A derivative of 2-acylaminothiazole or a salt thereof
HK1215689A1 (zh) 面部肌肉鍛鍊器
PL3018257T3 (pl) Słupek bariery
GB2526178B (en) Horse-riding training device
PL3085227T3 (pl) Trenażer ruchu dla małych zwierząt
GB201608979D0 (en) Intraosseous infusion training system
GB2532578B (en) Animal amusement device
GB2522069B (en) Bird guard device
GB2522427B (en) A training device
GB201405348D0 (en) Training cassette for auto-injector
GB2524086B (en) A deterrent device
GB201402820D0 (en) Fence attachment device
ZA201705079B (en) Deterrent device
GB2546148B (en) Animal deterrent
GB201615786D0 (en) Animal training aid
ES1144811Y (es) Aparato de musculación
GB201415801D0 (en) Cat Fight Deterrent Colar
GB201509604D0 (en) Trainers etc
UA31160S (uk) Комбінезон для фітнесу
ZA201502070B (en) A training device
HK1194600A2 (en) Pets jacuzzi